Country Analytics & Portfolio Lead — Data-Driven Impact

Roche; Warszawa; Hybrid; PLN 240,000 - 300,000; Full time

Benefits offered by this job

Annual bonus

Company car

Dedicated training budget

Recharge Fridays

Take Time Program

Vacation subsidy

Flex Location

Private healthcare

Job summary

Roche Polska sp. z o.o. in Warsaw is seeking a Country Analytics and Portfolio Optimization Lead to drive data-driven decisions across Clinical Operations. Based in Warsaw, you will implement APO solutions, monitor portfolio performance, and collaborate with cross-functional teams to address business challenges.

This hybrid role emphasizes analytics leadership, data literacy, and patient-centricity, with a fixed-term contract through October 31, 2027 and a competitive package.

Qualifications

• Bachelor’s degree with 7+ years of experience (or Master’s with 5+ years; PhD/JD with 3+ years).
• Deep understanding of clinical operations and drug development processes.
• Strong data analytics, statistics, and data architecture knowledge; ability to leverage AI tools.

Responsibilities

• Translate business requirements into analytical solutions and identify complex problems.
• Monitor, optimize and report portfolio delivery performance with clear KPIs.
• Foster data literacy and act as the primary analytics contact for teams.
• Collaborate with cross-functional partners to deliver analytical solutions for specific business problems.
• Champion patient-centricity across clinical operations and investigator interactions.

Skills

Analytics leadership

Data literacy

Cross-cultural collaboration

Independent leadership

Statistical analysis

Education

Bachelor's degree

Master's degree

PhD/JD

Job description

Roche Polska sp. z o.o. in Warsaw is seeking a Country Analytics and Portfolio Optimization Lead to drive data-driven decisions across Clinical Operations. Based in Warsaw, you will implement APO solutions, monitor portfolio performance, and collaborate with cross-functional teams to address business challenges.

This hybrid role emphasizes analytics leadership, data literacy, and patient-centricity, with a fixed-term contract through October 31, 2027 and a competitive package.